Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
Velidedeoğlu
E
E
Turkish Transplantation and Burn Foundation Hospital, Ankara.
Tokyay
R
R
Haberal
M
M
D000017:ABO Blood-Group System / Q000276:immunology; D000328:Adult; D001803:Blood Transfusion; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D016017:Odds Ratio; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D014019:Tissue Donors
D000017:ABO Blood-Group System; D016572:Cyclosporine